Cathal Friel reverses Open Orphan into listed Venn Life Sciences10th May 2019 https://otp.investis.com/clients/uk/amryt_pharmaceuticals_dac1/rns/regulatory-story.aspx?cid=1375&newsid=1218097 PrevNext
